Loading stockData sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Loading stockData sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Not financial advice. Analytical data for research only.
Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.
Bilendi S.A. is a prominent data collection and market research company that operates internationally, specializing in digital and digital-enhanced research solutions. Its primary function is to gather, analyze, and provide insights through high-quality data collected from a vast array of consumer panels around the globe. Bilendi S.A. plays a crucial role in helping businesses across multiple sectors, including retail, automotive, healthcare, and technology, to understand consumer behavior and market trends effectively. The company is known for its innovative approach to data collection, utilizing advanced technology and proprietary software to ensure comprehensive and accurate data delivery. This precision helps organizations make informed decisions regarding product development, marketing strategies, and customer engagement. Within the financial market, Bilendi S.A. serves as a key facilitator of impactful market research services, offering valuable information that can guide strategic business initiatives and investments. Established in France, Bilendi S.A. continues to expand its global reach, emphasizing its commitment to delivering high-value data insights to clients worldwide.
€10.66
€0.32 (-2.91%)
EOD Sep 11, 2026
Operating margin is thin at 6.08%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue grew 42.2%, still solid. Margins contracted 5.0pp, which offsets some of the top-line progress.
Free cash flow declined 39% versus the prior year, cash generation momentum has weakened. ROIC dropped from 9.37% to 7.26%, capital efficiency is deteriorating.
17.3x earnings, 9.9x FCF. Valuation is in a reasonable range. The main question is whether the business can re-accelerate or if current trajectory is already priced in.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
€92M
▲ +42.2% YoY
Net Income (TTM)
€3M
▼ -34.4% YoY
Op. Margin
6.08%
▼ -5.0pp YoY
ROIC
7.26%
▼ -2.1pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
€5M
▼ -39.4% YoY
Op. Cash Flow (TTM)
€5M
▼ -36.8% YoY
Net Debt
€48M
Cash & Equiv.
€10M
3Y CAGR: +14.2%
3Y CAGR: +33.8%
Continue Research
At a P/E of 17.3 and a price-to-free-cash-flow of 9.9, Bilendi (ALBLD.XPAR) trades below a two-stage DCF intrinsic value of about €15.40 per share, so at €10.66 the stock looks undervalued (44.5% below estimated intrinsic value). A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Bilendi scores 57/100 on Intrinsiqq's quality scorecard (a mixed business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full methodology. This is analysis, not investment advice.
Intrinsiqq's two-stage DCF estimates an intrinsic value of about €15.40 per share for ALBLD.XPAR, projecting its recent free cash flow forward with a growth rate that fades toward a long-run rate and discounting it back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around €11.55. At today's €10.66, that puts the stock about 44.5% below estimated intrinsic value. The result is sensitive to the growth and discount-rate inputs, so it is best to run conservative, base and optimistic cases. You can adjust all of them yourself with the sliders on the DCF tab.
Bilendi scores 57 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which makes it a mixed business on these measures. Recent fundamentals include a 6.1% operating margin and a 7.3% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. ALBLD.XPAR currently trades below its estimated intrinsic value and scores 57/100 on quality (mixed). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.